Joshua R Veatch

3PUBLICATIONS
60CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 09, 2026
Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma.

|Mar 04, 2026
Response of B Cells Specific for Polyomavirus-Derived Oncoprotein Is Predictive of Merkel Cell Carcinoma Tumor Control.

Haroldo J Rodriguez Chevez, Allison J Remington, Matthew D Gray

|Dec 10, 2020
Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumab.

Joshua R Veatch, Naina Singhi, Brenda Jesernig

Pageof 1

Frequent Collaborators

2 joint publications

Paul Nghiem

2 joint publications

David M Koelle

2 joint publications

Cecilia C S Yeung

1 joint publications

Aude G Chapuis